Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Cheryl Lang"'
Autor:
Scott G. Weiner, Scott A. Goldberg, Cheryl Lang, Molly Jarman, Cory J. Miller, Sarah Li, Ewelina W. Stanek, Eric Goralnick
Publikováno v:
Western Journal of Emergency Medicine, Vol 25, Iss 3, Pp 320-324 (2024)
Introduction: Bystander provision of naloxone is a key modality to reduce opioid overdose-related death. Naloxone training courses are available, but no standardized program exists. As part of a bystander empowerment course, we created and evaluated
Externí odkaz:
https://doaj.org/article/7bfb9b506f814cde8f3ad19150753f81
Autor:
Sofia Amylidi‐Mohr, Cheryl Lang, Beatrice Mosimann, Georg M. Fiedler, Christoph Stettler, Daniel Surbek, Luigi Raio
Publikováno v:
Amylidi-Mohr, Sofia; Lang, Cheryl; Mosimann, Beatrice; Fiedler, Georg M; Stettler, Christoph; Surbek, Daniel; Raio, Luigi (2023). First-trimester glycosylated hemoglobin (HbA1c) and maternal characteristics in the prediction of gestational diabetes: An observational cohort study. Acta obstetricia et gynecologica Scandinavica, 102(3), pp. 294-300. Wiley-Blackwell 10.1111/aogs.14495
INTRODUCTION This study aimed to investigate the extent to which gestational diabetes mellitus (GDM) can be predicted in the first trimester by combining a marker of growing interest, glycosylated hemoglobin A1c (HbA1c), and maternal characteristics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::125fb4afb81c1c8c085d4f4d01117291
https://pubmed.ncbi.nlm.nih.gov/36524557
https://pubmed.ncbi.nlm.nih.gov/36524557
Autor:
Cheryl Lang, Sandra L. Nehlsen-Cannarella, Abubakr A. Imam, Rudolph P. Valentini, Tej K. Mattoo, Scott A. Gruber, Miguel S. West
Publikováno v:
Pediatric Transplantation. 11:77-81
The use of intravenous immunoglobulin (IVIG) in sensiti- zed transplant candidates has resulted in reduced HLA antibody levels and shorter transplant wait times. In addition, the HLA- Matchmaker program has been used to identify acceptable mis- match
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7782565830eefa86c0d44e7f7b435f5
https://doi.org/10.1111/j.1399-3046.2006.00617.x
https://doi.org/10.1111/j.1399-3046.2006.00617.x
Autor:
Betty Cummings, Rosemary Fallon, Kate McGovern, Patti Rager Zuzelo, April Lang, Cheryl Lang, Lisa Mount
Publikováno v:
Clinical Nurse Specialist. 18:207-217
PURPOSE The purpose of this study was to describe clinical nurse specialists' (CNSs) knowledge of Medicare structures and processes using a multiple-choice examination. DESIGN This descriptive study used the survey method with a convenient sample. SE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42a46ff579cdab6a1e4c120ff5327da0
https://doi.org/10.1097/00002800-200407000-00012
https://doi.org/10.1097/00002800-200407000-00012
Publikováno v:
The ABNF journal : official journal of the Association of Black Nursing Faculty in Higher Education, Inc. 17(1)
Focus groups with African American women who had experienced a breast biopsy were conducted during the process of "getting ready" for a breast biopsy educational study in which the intervention's educational materials and study instruments were devel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b5484508ed37fb0a998a4e6862527aa8
https://pubmed.ncbi.nlm.nih.gov/16596896
https://pubmed.ncbi.nlm.nih.gov/16596896
A phase 2 study of brentuximab vedotin in patients with CD30-positive advanced systemic mastocytosis
Autor:
Jason Gotlib, John H. Baird, Tracy I. George, Cheryl Langford, Isabel Reyes, Justin Abuel, Cecelia Perkins, Kurt Schroeder, Prithviraj Bose, Srdan Verstovsek
Publikováno v:
Blood Advances, Vol 3, Iss 15, Pp 2264-2271 (2019)
Abstract: There is an unmet need for effective therapies for advanced systemic mastocytosis (advSM). CD30 is expressed on the surface of neoplastic mast cells (MC) in more than 50% of patients with advSM. Brentuximab vedotin (BV) is a CD30-directed a
Externí odkaz:
https://doaj.org/article/78e7499661ed40a9b6797da25f473048